» Articles » PMID: 8395306

The Kappa-opioid Receptor Agonist U-69593 Attenuates Cocaine-induced Behavioral Sensitization in the Rat

Overview
Journal Brain Res
Specialty Neurology
Date 1993 Jul 9
PMID 8395306
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of treatment with the selective kappa-opioid receptor agonist U-69593 upon cocaine-induced changes in locomotor activity and stereotypy were examined in rats. U-69593 (0.16 mg/kg s.c.) administered either acutely or chronically attenuated both the motor stimulant effect and stereotypy produced by an acute injection of cocaine (20 mg/kg i.p.). Daily cocaine treatment resulted in sensitization to both effects of cocaine. In contrast, no such sensitized responses were seen in animals which had received U-69593 either prior to or in conjunction with daily cocaine treatment. These data demonstrate that activation of kappa-opioid receptors attenuates the acute and chronic effects of cocaine on locomotor activity and stereotypy. Given the inhibitory effects ascribed to both exogenous and endogenous kappa-opioid agonists upon dopamine release in the mesolimbic dopaminergic system, it is suggested that this action may underlie the observed effects of U-69593 on cocaine-induced changes in locomotor activity and stereotypy.

Citing Articles

Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Gibula-Tarlowska E, Kotlinska J Biomolecules. 2020; 10(10).

PMID: 32998249 PMC: 7599993. DOI: 10.3390/biom10101376.


Role of Long Noncoding RNA Gas5 in Cocaine Action.

Xu H, Brown A, Waddell N, Liu X, Kaplan G, Chitaman J Biol Psychiatry. 2020; 88(10):758-766.

PMID: 32711952 PMC: 7584769. DOI: 10.1016/j.biopsych.2020.05.004.


Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.

Valenza M, Windisch K, Butelman E, Reed B, Kreek M Psychopharmacology (Berl). 2020; 237(4):1147-1160.

PMID: 31915862 DOI: 10.1007/s00213-019-05444-4.


Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Liu S, Pickens S, Burma N, Ibarra-Lecue I, Yang H, Xue L J Neurosci. 2019; 39(21):4162-4178.

PMID: 30862664 PMC: 6529867. DOI: 10.1523/JNEUROSCI.0274-19.2019.


Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.

Dang D, Shin E, Kim D, Tran H, Jeong J, Jang C J Neuroinflammation. 2018; 15(1):52.

PMID: 29467000 PMC: 5822489. DOI: 10.1186/s12974-018-1087-7.